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ABSTRACT A stable complex between pentaamminerutheni-
um(III) and histidine-33 in horse heart ferricytochrome c is formed
in the reaction between aquopentaammineruthenium(II) and the
protein at pH 7. HPLC of the tryptic hydrolysate of the modified
protein was employed to identify the pentaammineruthenium
binding site. Spectroscopic measurements show that the integrity
of the native structure in the vicinity of the heme c group is main-
tained in the ruthenium-modified protein. The reduction poten-
tials are: heme c (Fe3+'2+), 0.26 V; Ru(NH3)5(His-33)3+'2+, 0.15
V (vs. normal hydrogen electrode).
A central theme of our research in bioinorganic chemistry has
been the elucidation of the factors that control the rates of me-
talloprotein electron transfer reactions. One factor that we know
to be important is the distance that separates the redox centers
of the protein and the substrate in the activated complex
undergoing electron transfer (1). To explore rate-distance re-
lationships in detail, we have begun to prepare protein deriv-
atives in which one or more redox-active metal complexes are
attached covalently to ligands supplied by the polypeptide
chains. The idea is to produce synthetic multisite metallopro-
teins, whose redox centers are fixed at several different sepa-
ration distances, and then to measure the intramolecular elec-
tron transfer rates at those known distances.
Matthews has shown (2-5) that Ru(NH3)5H202+ is a good
reagent for modification of histidine residues in proteins, and
we have found that the reaction of Ru(NH3)5H202' with horse
heart cytochrome c, followed by oxidation, produces several
stable Ru(NH3)53+-ferricytochrome c derivatives. Characteriza-
tion of one of these derivatives, Ru(NH3)5(His-33)3+-ferricyto-
chrome c, is reported here.
MATERIALS AND METHODS
Horse heart cytochrome c (type VI) was obtained from Sigma.
The protein was purified by cation exchange chromatography
on carboxymethylcellulose (6). Trypsin treated with N-tosyl-
phenylalanine chloromethyl ketone was from Worthington.
Baker HPLC reagent-grade acetonitrile was used for HPLC.
Ruthenium atomic absorption standard solutions were obtained
from Alfa-Ventron and Aldrich. 4,4-Bipyridyl'2H20 was ob-
tained from Aldrich and was recrystallized from water. Mate-
rials for column chromatography were AG50W-X2, 200 mesh
(Bio-Rad); CM52 (Whatman); Sephadex G-25-150 (Sigma).
Protein Modification (at California Institute of Technol-
ogy). Cytochrome c was reacted with Ru(NH3)5H2O2+ under
argon at room temperature in 85 mM sodium phosphate buff-
er (pH 7.0) for 24-72 hr. Each preparation generally employed
100 mg of purified cytochrome c at a concentration of ca.
0.2 mM, and a 50-fold excess of ruthenium reagent ([Ru] 10
mM). Ru(NH3)5H202+ was generated by the reduction of
[Ru(NH3)5CI]CI2 (7, 8) over zinc/mercury amalgam or
[Ru(NH3)5H20](PF6)2 (9) was used directly. The reaction was
terminated by applying the solution to a Sephadex G-25 col-
umn. The pooled fractions from the Sephadex column were
oxidized and concentrated in a stirred ultrafiltration cell. Prior
to rechromatography or other experiments, materials were
equilibrated into the buffer ofchoice (or water) by several cycles
of dilution and ultrafiltration. The components of the mixture
from the Sephadex column were separated by cation exchange
chromatography on a 2 x 50-60 cm column of Whatman CM-
cellulose (CM52) that had been equilibrated with 85 mM phos-
phate buffer (pH 7.0). All ion exchange chromatography was
performed at 40C. The chromatogram was developed by a linear
gradient between 1.0 liter each of 85 mM and 150 mM sodium
phosphate buffer (pH 7.0) at a flow rate of ca. 30 ml/hr. Five-
milliliter fractions were collected, and the absorbance of every
other fraction was read at 410 nm.
Five distinct peaks (A-E) from four separate Ru(NH3)5Cl2+/
Zn (amalgam) preparations were pooled and purified as follows:
Peak A (ca. 32 mg ofcytochrome c) was rechromatographed on
acolumn (2.3 x 32 cm) ofCM52 with 85 mM sodium phosphate
buffer (pH 7.0); peak B (ca. 42 mg) was rechromatographed on
CM52 with 85 mM sodium phosphate buffer (column bed, 2.3
X 26 cm); peak C (ca. 48 mg) also was eluted from a CM52 col-
umn (2.3 x 19 cm) with 85mM sodium phosphate buffer; peaks
D (ca. 24 mg) and E (ca. 43 mg) were rechromatographed on
CM52 with 100 mM sodium phosphate buffer (pH 7.0). Column
beds were 2.3 x 19 cm (peak D) and 2.3 X 17 cm (peak E). In
all cases, a flow rate of 30 ml/hr was maintained and 5-ml frac-
tions were collected. The absorbance ofevery other fraction was
read at 410 nm.
The fractions corresponding to each of the major species that
eluted upon rechromatography were pooled (A'-E'). All ex-
periments reported here are for E' (concentrated solutions that
were to be used within a few days were kept at 4°C; other sam-
ples were shell-frozen in liquid nitrogen and stored at - 100C)
or its analogue in the Rutgers' preparation. E' was analyzed for
Ru by flame atomic absorption. The Ru/heme c ratio was found
to be 1:1 (± 10%).
Protein Modification (at Rutgers). A 20-ml solution of
Ru(NH3)5H202+ (-0.2 M) was prepared by zinc/mercury
amalgam reduction of Ru(NH3)5Cl2+. The pH was adjusted to
7 with 100 mM phosphate buffer and cytochrome c (125 mg)
Abbreviations: AUFS, absorbance unit full scale; SSCE, saturated NaCl
calomel electrode; NHE, normal hydrogen electrode.
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(0.01 mmol in 3 ml of 100 mM phosphate buffer contained in
a dialysis bag) was added to the ruthenium solution. After 48
hr, the dialysis bag was removed and washed (four washes of
50 ml each) with ascorbic acid solution in an ultrafiltration cell
by using a UM05 membrane. The solution then was concen-
trated to 10 ml and potassium ferricyanide (2 equivalents) was
added with stirring. The solution then was charged onto a CM52
cellulose column (45 x 1.5 cm) (equilibrated with 100mM phos-
phate buffer at pH 7). The first band eluted from this column
with 100 mM phosphate. The second band eluted when a KCl/
phosphate buffer salt gradient was used. A third band remained
at the top of the column and did not elute with 1 M KCI. The
second band (analyzed as the ruthenium-modified cytochrome
c) was collected, washed with water, and Iyophilized. The first
band was native protein (no detectable ruthenium). The second
band had a Ru/Fe ratio of 1:1 (± 10%) by flame atomic ab-
sorption and chemical analyses.
Tryptic Hydrolyses. The protein (native or E') was digested
by trypsin and the resulting peptides were separated by HPLC
(10). A 4-mg sample ofthe cytochrome c species in 2 ml ofwater
was adjusted to pH 8.5 with 0.1 M NaOH. NH4HCO3 was
added to give a concentration of 0.025 M. At 0 and 6 hr, 25 uld
of trypsin solution (2 mg/ml in 0.001 M HCI) was added. The
solution was stirred at 370C for a total of 24 hr. The pH of the
solution then was lowered to 2.1. After filtration through a 0.5-
,tm cellulosic membrane filter, the solution was lyophilized to
dryness. The lyophilized material was dissolved in chromatog-
raphy pH 2.85 phosphate buffer (49 mM KH2PO4/5.4 mM
H3PO4) and refiltered. A 2-mg sample of the filtered cyto-
chrome c dissolved in 0.1 ml of pH 2.85 phosphate buffer was
injected onto the HPLC column (Altex Ultrasphere, Berkeley,
CA; 4.6 x 250 mm). The peptides were eluted in 120 min with
a linear gradient from 0 to 45% in acetonitrile at a flow rate of
1 ml/min. Absorbance at 220 nm was recorded at 1.0 absor-
bance unit full scale (AUFS); absorbance at 300 nm was recorded
Acetyl-Gly-Asp-Val-Glu-Lys Gly-Lys
TI -T2
at 0. 1 AUFS. Fraction size was 0.5 ml. Fractions corresponding
to those peaks that were later subjected to amino acid analysis
or examined spectrally were pooled and blown dry with filtered
air in a 40°C water bath.
Amino Acid Analyses. These experiments employed a mod-
ified Beckman 120 amino acid analyzer. The sensitivity of the
instrument was such that 5 nmol of amino acids was adequate
for calculation.
Spectra. Spectra of HPLC fractions were recorded on a
Hewlett-Packard 8450 UV-Vis spectrophotometer with a 7225A
Graphics Plotter. The dried sample corresponding to a given
HPLC peak was rediluted with 1 ml of water and the spectrum
was recorded in a small volume, 1-cm cell. The pH of the so-
lution was -3. Other optical absorption spectral measurements
were made on Cary 219 and Cary 118C spectrophotometers.
Circular dichroism spectra were measured on a Cary 60. NMR
spectra were obtained on a Bruker 360 MHz instrument.
Cyclic Voltammetry. For these experiments a PAR 174A
potentiostat was used in conjunction with a Hewlett-Packard
7004B-X-Y recorder. A Keithley 177 Microvolt DMM voltmeter
was used to confirm the starting potential prior to a scan. The
all-glass cell consisted of two compartments separated by a sin-
tered glass disk. It also was equipped with a side arm for de-
gassing the sample. The working electrode was a gold disk (3
mm in diameter), and the auxiliary electrode was a coil of plat-
inum wire. The reference electrode was a saturated NaCl cal-
omel electrode (SSCE). Solutions of cytochrome c (1.5-2.0 ml
of 0.1-0.2 mM) also were 0.1 M in 4,4'-bipyridyl (11). The sup-
porting electrolyte was 0.1 MI NaCl04 in sodium phosphate
buffer (pH 7, IL = 0.05 M). All solutions were deoxygenated
by bubbling with argon for several minutes prior to use.
RESULTS AND DISCUSSION
The site of attachment of Ru(NH3)53+ to the protein in E' was
identified by locating and isolating the ruthenium-containing
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FIG. 1. The tryptic peptides (T1-T18) of horse heart cytochrome c (vertical lines indicate the points of hydrolysis by trypsin). Potential
Ru(NH3)53" ligands are His-26 (T6), His-33 (T7), and Met-65 (T11).
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FIG. 2. Reversed-phase HPLC of tryptic digests of native cyto-
chrome c and Ru(NH3)53+-cytochrome c (E') at A220 (1.0 AUFS). A 2-
mg sample of hydrolyzed protein was chromatographed with a linear
gradient between 0% and 45% acetonitrile in pH 2.85 phosphate buffer
in 120 min. The labeled peaks were identified by amino acid analyses.
tryptic peptide (Fig. 1). The separations of the tryptic digests
of both native cytochrome c and E' on a reversed-phase HPLC
column are shown in Fig. 2. The major difference between the
chromatograms of the native and ruthenium-modified proteins
is in the position ofpeptide Ti. This (His-33)-containing peptide
has shifted to a considerably lower elution volume in the HPLC
ofthe ruthenium-modified cytochrome c. Analytical data (num-
bers of amino acid residues) confirm that the modified peptide
is Ti: Lys, 0.16; His, 0.87; Arg, 0.94; Asp, 1.27; Thr, 0.90; Glu,
0.38; Pro, 0.93; Gly, 2.90; Ala, 0.34; Ile, 0.34; Leu, 2.24; Tyr,
0.31; Phe, 0.94.
The HPLC ofa native cytochrome c tryptic digest was rerun,
this time monitoring the absorbance of the eluting peptides at
300 nm (Fig. 3). In the 300-nm chromatogram ofnative protein,
only the peaks corresponding to the T10 (tryptophan containing)
and T4 (heme containing) peptides are evident but, in addition,
a new peak at an elution volume of =60 ml is observed in the
Ru(NH3)53' derivative. This peak is identified as the Ti peptide
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FIG. 4. (A) Absorption spectrum of the (His-33)-containing pep-
tide, T7, of Ru(NH3)53+-cytochrome c (E'), isolated by tryptic hydrol-
ysis and HPLC (Fig. 3); pH 3. (B) Absorption spectrum of a 0.2 mM
solution of [Ru(NH3)5His]1Cl3; pH 7.
by comparison with the 220-nm chromatogram of the Ru(NH3)53+-
cytochrome c (Fig. 2). The attachment of Ru(NH3)53+ to His-33
in the T7 peptide makes it possible to detect T7 at 300 nm in
A
9.5 9.0 8.5 8.0
B
9.5 9.0 8.5 8.0
ppm
FIG. 3. Reversed-phase HPLC of tryptic digests of native cyto-
chrome c and Ru(NH3)53+-cytochrome c (E') at 300 nm (0.1 AUFS)
(same conditions as in Fig. 2). The labeled peaks were identified by
analogy to the 220-nm chromatograms.
FIG. 5. High-field (360 MHz) NMR spectra of native (A) and
Ru(NH3)53+-modified (B) ferricytochromes c (pH 5, 250C, 2H20) in the
region of imidazole C-2 proton resonances [internal 2,2-dimethyl-2-
silapentane-5-sulfonate (DSS)].
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FIG. 6. Direct current cyclic voltammetry of E' and related spe-
cies. All species are in pH 7 phosphate buffer (Ip = 0.05 M) (gold elec-
trode) in the presence of 0.01 M 4,4'-bipyridyl. Scan rate = 5 mV/s.
(A) Native cytochrome c, 0.21 mM: E1,2 = 27 3 mV (263 3 mV vs.
NHE). (B) Native cytochrome c, 0.21 mM, with [Ru(NH3)5His]C13, 0.21
mM: E112 (heme c) = 19 + 1 mV (255 1 mV vs. NHE); Ei12
[Ru(NH3)5His3+'2+] = - 128 2 mV (108 2 mV vs. NHE). (C) E',
0.12 mM: E112 (heme c) = 21 3 mV (257 ± 3 mV vs. NHE); Ei,2
[Ru(NH3)5(His-33)3+/2+] = 85 ± 3 mV (151 ± 3 mV vs. NHE).
the modified protein [the spectrum of Ru(NH3)5His3+ exhibits
a peak at 303 nm (molar extinction coefficient s = 2,100
M-1 cm-1) (12)]. The fractions corresponding to the T7 peptide
in the 300-nm chromatogram of Ru(NH3)53+-cytochrome c were
collected, dried, and redissolved in water. The spectrum of the
modified T7 peptide is exactly that of Ru(NH3)5His3+ with an
additional peak at 275 nm attributable to the presence of Phe
in the T7 peptide (Fig. 4).
The Ru(NH3)53+ binding site also was confirmed by high-
field NMR measurements (Fig. 5). The general features in the
spectrum of the ruthenium derivative are broader than those
observed for the native protein, and it is apparent that the His-
33 C-2 proton resonance (13) at 8.84 ppm (Fig. 5A) is absent in
Fig. 5B.
The visible and ultraviolet spectra ofE' in both the oxidized
and dithionite-reduced forms are indistinguishable from those
of native cytochrome c. In the fully oxidized state, features at-
tributable to Ru(NH3)5His3+ are obscured by heme absorption
in the spectrum. The presence of the conformation-sensitive
695-nm band (14) in the spectrum of the oxidized ruthenium-
modified protein indicates that the heme c site is not perturbed
significantly. A similar conclusion follows from the observation
that the ultraviolet circular dichroism spectra of native and
modified cytochromes are virtually identical.
The ruthenium derivative is ideally suited for the electron
transfer kinetic studies mentioned earlier. The attached
Ru(NH3)53+ group is inert to substitution, and by cyclic voltam-
metry we have demonstrated that both the heme c [0.26 V vs.
normal hydrogen electrode (NHE)] and Ru(NH3)5(His-33)3+
(0.15 V vs. NHE) centers are redox-active (Fig. 6). One im-
portant result that emerges is that the heme c potential is un-
perturbed by the presence of the Ru(NH3)53+ group on the sur-
face of the protein. Elucidation of the factors that tune the
potential of Ru(NH3)5(His-33)3+ 40 mV higher than that of iso-
lated Ru(NH3)5His3+ is an important subject that remains to be
explored.
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